HQL Insider Trading Activity and SEC Form 4 Filings
HQL insider trading summary
Over the past 12 months, insiders at abrdn Life Sciences Investors (HQL) reported 2 open-market purchases worth $144K by 2 insiders and no sales on SEC Form 4. Net insider buying was $144K.
Latest HQL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 16, 2026 | Chris LaVictoire Mahai | Director | Buy | $10K (527 @ $19.92) |
| Dec 16, 2025 | Christian Pittard | Director | Buy | $134K (7,923 @ $16.88) |
| Sep 22, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | $589K (41,623 @ $14.14) |
| Sep 19, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | $99K (6,989 @ $14.10) |
| Sep 18, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | $566K (40,208 @ $14.07) |
| Sep 17, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | $340K (24,328 @ $13.99) |
| Sep 16, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | $28K (2,026 @ $13.99) |
| Sep 15, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | $10K (700 @ $14.13) |
| Sep 11, 2025 | Saba Capital Management, L.P. | 10% Owner | Sell | $216K (15,116 @ $14.28) |
| Sep 2, 2025 | Boaz Weinstein | 10% Owner | Sell | $198K (14,083 @ $14.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.